Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report
Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). Convalescent plasma has not yet been approved for use in patients with COVID19 infection; however, it is regulated as an investigational product. This is a case report of a 55-year-old male, wit...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13581
- Acceso en línea:
- https://doi.org/10.1016/j.radcr.2020.07.031
http://hdl.handle.net/20.500.12010/13581
- Palabra clave:
- COVID-19
RT-PCR
Convalescent plasma transfusion
Groung-glass opacities
Crazy paving appearance
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)
| Summary: | Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). Convalescent plasma has not yet been approved for use in patients with COVID19 infection; however, it is regulated as an investigational product. This is a case report of a 55-year-old male, with COVID-19 pneumonia who has received convalescent plasma as part of a treatment plan which showed significant radiological and clinical improvement post-treatment |
|---|